Why Most IP Assignment Clauses in Research Agreements Sabotage the Deal Later

The clause gets buried on page eight. Everyone signs. The science proceeds. Then, three years later, when the startup is closing a Series A and the lead investor's counsel requests a clean IP chain-of-title opinion, the whole deal stalls on a sentence nobody thought twice about in 2021.

Photo by Thirdman on Pexels.

This happens more than the technology transfer community likes to admit. IP assignment language in sponsored research agreements (SRAs) is treated as boilerplate when it should be treated as a term sheet. The decisions made in that clause determine who owns what, who can license what, and whether a future investor or acquirer will see a clean asset or a legal minefield.

The most common failure mode is ambiguity about "background IP" versus "foreground IP." Background IP is what the university (or company) brings into the collaboration. Foreground IP is what gets created during it. Sounds simple. The problem is that real research does not respect those categories. A graduate student extends an existing university algorithm to solve the sponsor's problem. Is the improved algorithm foreground? Background? A joint invention? The answer depends entirely on how the agreement defines "improvement" and "derived from," and most agreements define neither.

Some SRAs use the phrase "IP arising from the research" as the trigger for assignment. That phrase is doing enormous work while being asked to do no work at all. Courts have read similar language in completely opposite directions. One jurisdiction treats "arising from" as requiring direct causation; another treats it as broad enough to cover any IP that wouldn't have existed but for the funded work. If your agreement doesn't specify, you're leaving ownership to a judge who knows nothing about your technology or your relationship.

Here's where it gets worse for spinouts specifically. When a faculty member founds a company and that company enters a sponsored research agreement with a corporate partner, the IP ownership question now runs through three entities: the university, the startup, and the sponsor. Most SRA templates were written for a two-party world. They handle the university-sponsor relationship reasonably well. They handle the university-spinout relationship poorly, and they almost never address what happens when the spinout is itself the contracting party rather than a passive licensee downstream.

Consider what a clean IP chain actually requires at exit:

graph TD
    A[Research Activity] --> B{Who Contributed?}
    B --> C[University Personnel Only]
    B --> D[Joint University + Sponsor]
    B --> E[Sponsor Personnel Only]
    C --> F(University Owns - License to Spinout)
    D --> G{Agreement Terms}
    G --> H[Joint Ownership per SRA]
    G --> I[Assigned to One Party]
    E --> J(Sponsor Owns - No University Claim)
    F --> K[Clean Title for Investment]
    I --> K
    H --> L[Requires Both Parties to License]

Joint ownership is often the worst outcome. Under U.S. patent law, each joint owner can license the patent to anyone without the other owner's consent and without sharing royalties. A corporate sponsor who co-owns a patent your spinout is built around can license it to your direct competitor. This is not a hypothetical. It has happened.

So what should negotiators actually insist on? A few concrete things:

First, define "improvement" with specificity. If improvements to background IP will be treated as foreground, say so explicitly. If they won't, say that too. The silence is the problem.

Second, include a "filed by" default. Specify which party has the first right to file patent applications on jointly invented foreground IP, and within what timeframe the other party can exercise step-in rights if the first party declines. Vague filing obligations lead to missed deadlines and abandoned rights.

Third, address the spinout scenario directly. If the university has an existing license with a related startup, the SRA should acknowledge that relationship and specify whether sponsored research results flow into that license, sit outside it, or require a separate sublicense negotiation.

Fourth, require an IP schedule at project completion. A brief written record of what was created, who contributed, and which category it falls into costs almost nothing to produce and prevents enormous disputes later. Very few agreements require this. All of them should.

None of this requires exotic legal drafting. It requires the people negotiating these agreements to treat IP ownership as the operational question it is, not as a formality to get past so the science can start. By the time the science is done, the window to fix the language has been closed for years.